{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:26:12Z","timestamp":1790652372189,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ando.2023.08.003","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T16:27:55Z","timestamp":1691857675000},"page":"697-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Position statement on the diagnosis and management of acromegaly: The French National Diagnosis and Treatment Protocol (NDTP)"],"prefix":"10.1016","volume":"84","author":[{"given":"Thierry","family":"Brue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha\u00effa","family":"Rahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoulaye","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Barlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Bertherat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Borson-Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Cazabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Christin-Maitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Cortet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Drui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kamenicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lan\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Liot\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Salenave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Tauveron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Touraine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Verg\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Vezzosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Coutant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Albarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2023.08.003_bib0740","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: review of population studies","volume":"20","author":"Lavrentaki","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib0745","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-21-0216","article-title":"Global epidemiology of acromegaly: a systematic review and meta-analysis","volume":"185","author":"Crisafulli","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0750","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge acromegaly survey (LAS) database","volume":"24","author":"Petrossians","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2023.08.003_bib0755","doi-asserted-by":"crossref","first-page":"101264","DOI":"10.1016\/j.beem.2019.02.001","article-title":"National acromegaly registries","volume":"33","author":"Maione","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib0760","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11102-016-0735-0","article-title":"\u201cMicromegaly\u201d: an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era","volume":"19","author":"Butz","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib0765","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1210\/jc.2011-2930","article-title":"Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases","volume":"97","author":"Garby","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib0770","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41574-018-0114-1","article-title":"The causes and consequences of pituitary gigantism","volume":"14","author":"Beckers","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0775","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/cen.13599","article-title":"Outcome of pregnancies in a large cohort of women with acromegaly","volume":"88","author":"Jallad","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0780","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ando.2012.09.004","article-title":"Acromegaly induced by ectopic secretion of GHRH: a review 30 years after GHRH discovery","volume":"73","author":"Borson-Chazot","year":"2012","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0785","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ando.2023.08.003_bib0790","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11102-016-0772-8","article-title":"Acromegaly: clinical features at diagnosis","volume":"20","author":"Vilar","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib0795","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1210\/jc.2016-1257","article-title":"Reference values for IGF-I serum concentrations: comparison of six immunoassays","volume":"101","author":"Chanson","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib0800","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an Endocrine Society Clinical Practice Guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib0805","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-19-0139","article-title":"Determinants of the growth hormone nadir during oral glucose tolerance test in adults","volume":"181","author":"Schilbach","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0810","first-page":"610","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2023.08.003_bib0815","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1530\/ERC-16-0356","article-title":"T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly","volume":"23","author":"Potorac","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2023.08.003_bib0820","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/ERC-15-0320","article-title":"Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients","volume":"22","author":"Rostomyan","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2023.08.003_bib0825","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","article-title":"Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"34","author":"Beckers","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2023.08.003_bib0830","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ando.2023.08.003_bib0835","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-12-0763","article-title":"Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don\u2019t forget MEN1 genetic analysis","volume":"168","author":"Cuny","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0840","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000345670","article-title":"Multiple endocrine neoplasia type 4","volume":"41","author":"Lee","year":"2013","journal-title":"Front Horm Res"},{"key":"10.1016\/j.ando.2023.08.003_bib0845","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11102-019-00974-8","article-title":"Acromegaly in Carney complex","volume":"22","author":"Cuny","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib0850","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","article-title":"Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation","volume":"371","author":"Trivellin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2023.08.003_bib0855","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","article-title":"A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case\u2013control study of 410 patients with 8 years post-operative follow-up","volume":"126","author":"The members of HYPOPRONOS","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ando.2023.08.003_bib0860","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00428-019-02655-0","article-title":"A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal","volume":"475","author":"Villa","year":"2019","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.ando.2023.08.003_bib0865","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00701-016-2903-4","article-title":"Surgical treatment of acromegaly according to the 2010 remission criteria: systematic review and meta-analysis","volume":"158","author":"Starnoni","year":"2016","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.ando.2023.08.003_bib0870","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1210\/jc.2014-2900","article-title":"Surgical interventions and medical treatments in treatment-na\u00efve patients with acromegaly: systematic review and meta-analysis","volume":"99","author":"Abu Dabrh","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib0875","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A consensus statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0880","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrendo.2014.21","article-title":"Expert consensus document: a consensus on the medical treatment of acromegaly","volume":"10","author":"Giustina","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0885","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.1.01824","article-title":"Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs","volume":"152","author":"Petrossians","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0890","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s11102-017-0832-8","article-title":"Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly","volume":"20","author":"Fahlbusch","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib0895","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s11102-015-0661-6","article-title":"Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results","volume":"18","author":"Carvalho","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib0900","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","article-title":"Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis","volume":"15","author":"Roelfsema","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib0905","doi-asserted-by":"crossref","first-page":"e61523","DOI":"10.1371\/journal.pone.0061523","article-title":"Place of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysis. Luque RM, \u00e9diteur","volume":"8","author":"Pita-Gutierrez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ando.2023.08.003_bib0910","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/EJE-14-0249","article-title":"Preoperative octreotide treatment of acromegaly: long-term results of a randomised controlled trial","volume":"171","author":"Fougner","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0915","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/cen.12553","article-title":"Should all patients with acromegaly receive somatostatin analogue therapy before surgery and, if so, for how long?","volume":"81","author":"Jacob","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0920","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","article-title":"Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a Pituitary Society statement","volume":"20","author":"Casanueva","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"A Pituitary Society update to acromegaly management guidelines","volume":"24","author":"Fleseriu","year":"2021","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib0930","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ando.2008.12.011","article-title":"French consensus on the management of acromegaly","volume":"70","author":"Chanson","year":"2009","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0935","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1210\/jc.2010-2443","article-title":"Place of cabergoline in acromegaly: a meta-analysis","volume":"96","author":"Sandret","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib0940","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ecl.2014.10.007","article-title":"Cabergoline use for pituitary tumors and valvular disorders","volume":"44","author":"Auriemma","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ando.2023.08.003_bib0945","doi-asserted-by":"crossref","first-page":"E1714","DOI":"10.1210\/jc.2012-1833","article-title":"No evidence of a detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly","volume":"97","author":"Maione","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib0950","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S2213-8587(14)70169-X","article-title":"Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial","volume":"2","author":"Gadelha","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0955","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-016-1029-z","article-title":"Hyperglycemia in pasireotide-treated patients with acromegaly and its treatment","volume":"54","author":"Luger","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.08.003_bib0960","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM200004203421604","article-title":"Treatment of acromegaly with the growth hormone\u2013receptor antagonist pegvisomant","volume":"342","author":"Trainer","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2023.08.003_bib0965","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ando.2015.10.003","article-title":"Pegvisomant treatment in patients with acromegaly in clinical practice: the French ACROSTUDY","volume":"76","author":"Chanson","year":"2015","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0970","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/EJE-18-0616","article-title":"Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY","volume":"179","author":"Buchfelder","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0975","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12020-018-1792-0","article-title":"Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy","volume":"63","author":"Brue","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.08.003_bib0980","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/eje.1.02079","article-title":"Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis","volume":"154","author":"Biering","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib0985","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1210\/jc.2014-3913","article-title":"Clomiphene citrate for treatment of acromegaly not controlled by conventional therapies","volume":"100","author":"Duarte","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib0990","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1210\/jc.2014-4113","article-title":"Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial","volume":"100","author":"Melmed","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib0995","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/EJE-18-0138","article-title":"A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly","volume":"179","author":"Trainer","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1000","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4158\/EP14575.DSCR","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: management of acromegaly patients: what is the role of pre-operative medical therapy?","volume":"21","author":"Fleseriu","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2023.08.003_bib1005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11102-018-0916-0","article-title":"Pre-surgical medical treatment, a major prognostic factor for long-term remission in acromegaly","volume":"21","author":"Albarel","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib1010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.2009.03620.x","article-title":"A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly: pegvisomant alone or combined with octreotide","volume":"71","author":"Trainer","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1507\/endocrj.EJ12-0272","article-title":"Efficacy of combined octreotide and cabergoline treatment in patients with acromegaly: a retrospective clinical study and review of the literature","volume":"60","author":"Suda","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2023.08.003_bib1020","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1210\/jc.2019-00825","article-title":"Pasireotide and pegvisomant combination treatment in acromegaly resistant to second-line therapies: a longitudinal study","volume":"104","author":"Chiloiro","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1025","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1210\/jc.2007-1234","article-title":"Long-term efficacy and safety of combined treatment of somatostatin analogs and pegvisomant in acromegaly","volume":"92","author":"Neggers SJCMM","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12020-020-02501-3","article-title":"Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study","volume":"71","author":"Kuhn","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.08.003_bib1035","doi-asserted-by":"crossref","first-page":"091","DOI":"10.1055\/s-0038-1625984","article-title":"Pediatric pituitary adenoma: case series, review of the literature, and a skull base treatment paradigm","volume":"79","author":"Perry","year":"2018","journal-title":"J Neurol Surg Skull Base"},{"key":"10.1016\/j.ando.2023.08.003_bib1040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11154-008-9106-0","article-title":"Modern techniques for pituitary radiotherapy","volume":"10","author":"Minniti","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.ando.2023.08.003_bib1045","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/jcem.85.10.6870","article-title":"Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center","volume":"85","author":"Barrande","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrendo.2010.4","article-title":"Role of stereotactic radiosurgery in the management of pituitary adenomas","volume":"6","author":"Castinetti","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1055","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0140-6736(09)61299-X","article-title":"CNS complications of radiotherapy and chemotherapy","volume":"374","author":"Soussain","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2023.08.003_bib1060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/cancers9080103","article-title":"Secondary intracranial tumors following radiotherapy for pituitary adenomas: a systematic review","volume":"9","author":"Yamanaka","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.ando.2023.08.003_bib1065","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/EJE-20-0652","article-title":"Evaluation of an individualized education program in pituitary diseases: a pilot study","volume":"183","author":"Albarel","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-16-1015","article-title":"Enhanced self-efficacy after a self-management programme in pituitary disease: a randomized controlled trial","volume":"177","author":"Andela","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1075","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/EC-15-0064","article-title":"Need for improved monitoring in patients with acromegaly","volume":"4","author":"Silverstein","year":"2015","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2023.08.003_bib1080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2265.2009.03556.x","article-title":"Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?","volume":"71","author":"Freda","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2265.2005.02199.x","article-title":"The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas","volume":"62","author":"Minniti","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.neurad.2018.02.004","article-title":"Radiotherapy in acromegaly: Long-term brain parenchymal and vascular magnetic resonance changes","volume":"45","author":"Milanese","year":"2018","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.ando.2023.08.003_bib1095","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2265.2006.02513.x","article-title":"Gamma knife radiosurgery for acromegaly? Long-term experience","volume":"64","author":"Je\u017ekov\u00e1","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11102-007-0002-5","article-title":"Treatment of acromegaly: is there still a place for radiotherapy?","volume":"10","author":"Jallad","year":"2007","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib1105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/EJE-19-0681","article-title":"follow-up relevant in patients with GH-secreting pituitary adenomas primarily treated and responsive to long-acting somatostatin analogues (SMSa)?","volume":"182","author":"Grandgeorge","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000446542","article-title":"Long-term remission of acromegaly after octreotide withdrawal is an uncommon and frequently unsustainable event","volume":"104","author":"Casagrande","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2023.08.003_bib1115","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1210\/jc.2018-01979","article-title":"How to Position Pasireotide LAR Treatment in Acromegaly","volume":"104","author":"Coopmans","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.diabet.2017.05.003","article-title":"Effects of anti-somatostatin agents on glucose metabolism","volume":"43","author":"Verg\u00e8s","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12020-018-1729-7","article-title":"Effectiveness and safety of pegvisomant: a systematic review and meta-analysis of observational longitudinal studies","volume":"63","author":"Leonart","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.08.003_bib1130","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1530\/EJE-13-0924","article-title":"Patients lost to follow-up in acromegaly: results of the ACROSPECT study","volume":"170","author":"Delemer","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1135","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic complications of acromegaly and the impact of the current treatment landscape: an update","volume":"40","author":"Gadelha","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2023.08.003_bib1140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/B978-0-444-59602-4.00014-9","article-title":"Acromegaly","volume":"124","author":"Chanson","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.ando.2023.08.003_bib1145","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1150","article-title":"Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep","volume":"30","author":"Randerath","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ando.2023.08.003_bib1155","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1210\/clinem\/dgz050","article-title":"The course of obstructive sleep apnea syndrome in patients with acromegaly during treatment","volume":"105","author":"Wolters","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-08-0442","article-title":"Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease","volume":"159","author":"Davi\u2019","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1165","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1210\/clinem\/dgz116","article-title":"Obstructive sleep apnea in acromegaly and the effect of treatment: a systematic review and meta-analysis","volume":"105","author":"Parolin","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1170","doi-asserted-by":"crossref","first-page":"e937","DOI":"10.1210\/clinem\/dgz096","article-title":"A consensus on the diagnosis and treatment of acromegaly comorbidities: an update","volume":"105","author":"Giustina","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1175","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1183\/13993003.01229-2016","article-title":"Acromegaly in sleep apnoea patients: a large observational study of 755 patients","volume":"48","author":"Galerneau","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ando.2023.08.003_bib1180","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/EJE-16-1064","article-title":"Changes in the management and comorbidities of acromegaly over three decades: the French acromegaly registry","volume":"176","author":"Maione","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/er.2013-1071","article-title":"Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications","volume":"35","author":"Kamenick\u00fd","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2023.08.003_bib1190","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1210\/jc.2015-2675","article-title":"Low frequency of cardiomyopathy using cardiac magnetic resonance imaging in an acromegaly contemporary cohort","volume":"100","author":"dos Santos Silva","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1195","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1210\/jc.2004-0821","article-title":"Long-term outcome of patients with acromegaly and congestive heart failure","volume":"89","author":"Bihan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1200","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11102-017-0827-5","article-title":"Incidence of myocardial infarction and stroke in acromegaly patients: results from the German acromegaly registry","volume":"20","author":"Sch\u00f6fl","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib1205","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12020-018-1571-y","article-title":"Oro-dental pathologies in acromegaly","volume":"60","author":"Kreitschmann-Andermahr","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.08.003_bib1210","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1530\/EC-20-0176","article-title":"Assessment of oro-dental manifestations in a series of acromegalic patients, the AcroDent study","volume":"9","author":"Roumeau","year":"2020","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2023.08.003_bib1215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1020754615863","article-title":"Acromegalic arthropathy","volume":"4","author":"Barkan","year":"2001","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib1220","series-title":"Actualit\u00e9s rhumatologiques 1997","first-page":"164","article-title":"Manifestations rhumatologiques de l\u2019acrom\u00e9galie","author":"Liot\u00e9","year":"1997"},{"key":"10.1016\/j.ando.2023.08.003_bib1225","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jbspin.2020.04.020","article-title":"Acromegaly is associated with vertebral deformations but not vertebral fractures: results of a cross-sectional monocentric study","volume":"87","author":"Plard","year":"2020","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ando.2023.08.003_bib1230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ando.2018.08.006","article-title":"Daily life, needs and expectations of patients with acromegaly in France: an on-line survey","volume":"80","author":"Albarel","year":"2019","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1235","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1210\/clinem\/dgaa747","article-title":"Progression of acromegalic arthropathy in long-term controlled acromegaly patients: 9\u00a0years of longitudinal follow-up","volume":"106","author":"Pelsma","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1240","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-19-0184","article-title":"Management of endocrine disease: Bone disorders associated with acromegaly: mechanisms and treatment","volume":"181","author":"Mazziotti","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1245","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1210\/jc.2014-2937","article-title":"Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis","volume":"100","author":"Mazziotti","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1250","doi-asserted-by":"crossref","first-page":"101279","DOI":"10.1016\/j.beem.2019.05.003","article-title":"Modern neuro-ophthalmological evaluation of patients with pituitary disorders","volume":"33","author":"Vi\u00e9","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1255","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10143-011-0365-y","article-title":"Prognostic factors of visual field improvement after trans-sphenoidal approach for pituitary macroadenomas: review of the literature and analysis by quantitative method","volume":"35","author":"Barzaghi","year":"2012","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.ando.2023.08.003_bib1260","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajo.2008.07.016","article-title":"Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography","volume":"147","author":"Jacob","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ando.2023.08.003_bib1265","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1210\/jc.2013-2480","article-title":"Pasireotide versus octreotide in acromegaly: a head-to-head superiority study","volume":"99","author":"Colao","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1270","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1210\/jcem.85.9.6775","article-title":"The prevalence and characteristics of colorectal neoplasia in acromegaly","volume":"85","author":"Renehan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1275","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11102-014-0586-5","article-title":"The role of colonoscopic screening in acromegaly revisited: review of current literature and practice guidelines","volume":"18","author":"Lois","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib1280","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1210\/jc.2009-1714","article-title":"Acromegaly is associated with an increased prevalence of colonic diverticula: a case-control study","volume":"95","author":"Wassenaar","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1285","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1634\/theoncologist.2019-0403","article-title":"Biliary stone disease in patients with neuroendocrine tumors treated with somatostatin analogs: a multicenter study","volume":"25","author":"Brighi","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.ando.2023.08.003_bib1290","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11102-013-0471-7","article-title":"Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients","volume":"17","author":"Alexopoulou","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib1295","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fendo.2018.00358","article-title":"Diabetes secondary to acromegaly: physiopathology, clinical features and effects of treatment","volume":"9","author":"Ferra\u00f9","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1300","doi-asserted-by":"crossref","first-page":"e00090","DOI":"10.1002\/edm2.90","article-title":"Hepatic steatosis in patients with acromegaly","volume":"2","author":"Koutsou-Tassopoulou","year":"2019","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1305","doi-asserted-by":"crossref","first-page":"E51","DOI":"10.1210\/jc.2012-2896","article-title":"The metabolic profile in active acromegaly is gender-specific","volume":"98","author":"Ciresi","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1310","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-18-0255","article-title":"Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis","volume":"179","author":"Bolfi","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1315","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/jc.2017-02457","article-title":"Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature","volume":"103","author":"Dal","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1320","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/EJE-16-0178","article-title":"Management of endocrine disease: acromegaly and cancer: an old debate revisited","volume":"175","author":"Boguszewski","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1325","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11102-017-0841-7","article-title":"Guidelines versus real life practice: the case of colonoscopy in acromegaly","volume":"21","author":"Parolin","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib1330","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/07435800500229177","article-title":"Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature","volume":"31","author":"Siegel","year":"2005","journal-title":"Endocr Res"},{"key":"10.1016\/j.ando.2023.08.003_bib1335","doi-asserted-by":"crossref","first-page":"e88787","DOI":"10.1371\/journal.pone.0088787","article-title":"Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly\u00a0\u2013\u00a0meta-analysis and systematic review. Khamseh ME, \u00e9diteur","volume":"9","author":"Wolinski","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ando.2023.08.003_bib1340","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40618-016-0565-y","article-title":"Risk of malignant neoplasms in acromegaly: a case\u2013control study","volume":"40","author":"Wolinski","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2023.08.003_bib1345","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ijc.32808","article-title":"Hormone-related diseases and prostate cancer: an English national record linkage study","volume":"147","author":"Watts","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ando.2023.08.003_bib1350","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-18-0925","article-title":"Patients\u2019 perspectives on acromegaly diagnostic delay: a qualitative study","volume":"180","author":"Sibeoni","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1355","doi-asserted-by":"crossref","first-page":"K19","DOI":"10.1530\/EJE-21-0537","article-title":"Acromegaly in remission: a view from the partner","volume":"185","author":"Fourneaux","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1530\/EJE-15-0888","article-title":"Morphometric changes correlate with poor psychological outcomes in patients with acromegaly","volume":"174","author":"Imran","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1365","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/cen.13331","article-title":"Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: results from a 5-years prospective study","volume":"86","author":"Kyriakakis","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.08.003_bib1370","doi-asserted-by":"crossref","first-page":"E373","DOI":"10.1210\/jc.2009-2556","article-title":"Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study","volume":"95","author":"Daly","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1375","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/jcm8111962","article-title":"The clinicopathological spectrum of acromegaly","volume":"8","author":"Akirov","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.ando.2023.08.003_bib1380","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1210\/clinem\/dgaa002","article-title":"Frequency and incidence of carney complex manifestations: a prospective multicenter study with a three-year follow-up","volume":"105","author":"Espiard","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1385","doi-asserted-by":"crossref","first-page":"E663","DOI":"10.1210\/jc.2011-2291","article-title":"Mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients","volume":"97","author":"Cazabat","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1390","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1210\/jc.2013-3826","article-title":"Acromegaly and mccune-albright syndrome","volume":"99","author":"Salenave","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1395","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1400","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-17-0933","article-title":"Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016","volume":"178","author":"McCormack","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1405","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/EJE-18-0795","article-title":"Treatment and long-term outcomes in pituitary carcinoma: a cohort study","volume":"181","author":"Santos-Pinheiro","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1410","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3390\/jcm8081107","article-title":"Novel treatments for pituitary tumors","volume":"8","author":"Ilie","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.ando.2023.08.003_bib1415","first-page":"19","article-title":"Octreotide use for rescue of vision in a pregnant patient with acromegaly","volume":"2019","author":"Hannon","year":"2019","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.ando.2023.08.003_bib1420","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/17446651.2019.1571909","article-title":"An update on clinical care for pregnant women with acromegaly","volume":"14","author":"Chanson","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1425","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-16-1059","article-title":"Management of endocrine disease: acromegaly and pregnancy: a contemporary review","volume":"177","author":"Abucham","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1430","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11102-019-01018-x","article-title":"Semen quality in hypogonadal acromegalic patients","volume":"23","author":"Andreassen","year":"2020","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib1435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006123-199907000-00001","article-title":"Growth hormone-secreting pituitary adenomas in childhood and adolescence: features and results of transnasal surgery","volume":"45","author":"Takumi","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2023.08.003_bib1440","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/ajmg.a.38308","article-title":"Growth hormone excess in children with neurofibromatosis type-1 and optic glioma","volume":"173","author":"Cambiaso","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ando.2023.08.003_bib1445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-017-0836-4","article-title":"Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes","volume":"21","author":"Nagata","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.08.003_bib1450","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000327831","article-title":"Clinical features and treatment of pediatric somatotropinoma: case study of an aggressive tumor due to a new AIP mutation and extensive literature review","volume":"75","author":"Personnier","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ando.2023.08.003_bib1455","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1210\/jc.2007-2283","article-title":"Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomant","volume":"93","author":"Goldenberg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.08.003_bib1460","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/eje.1.01829","article-title":"Consensus statement on the management of the GH-treated adolescent in the transition to adult care","volume":"152","author":"Clayton","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1465","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1530\/EJE-19-0298","article-title":"Endocrinology and adolescence: dealing with transition in young patients with pituitary disorders","volume":"181","author":"Sbardella","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.08.003_bib1470","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/EC-20-0520","article-title":"Transition of young adults with endocrine and metabolic diseases: the \u2018TRANSEND\u2019 cohort","volume":"10","author":"Le Roux","year":"2021","journal-title":"Endocr Connect"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426623006868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426623006868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:26:01Z","timestamp":1762086361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426623006868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":147,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0003426623006868"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2023.08.003","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Position statement on the diagnosis and management of acromegaly: The French National Diagnosis and Treatment Protocol (NDTP)","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2023.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}